BRIGHAM AND WOMEN'S HOSPITAL, INC., THE

Brigham and Women's Hospital, Inc. specializes in advanced biomedical research, translational medicine, and health services analytics. Their core capabilities include the development of cellular production platforms, specifically for beta cell sorting and editing, and the creation of targeted immunomodulatory therapies such as IL-10-mRNA for lupus nephritis. The organization possesses deep technical expertise in profiling synovial tissue biopsies to determine treatment responses in rheumatoid arthritis and leveraging electronic health records to optimize treatment selection for multiple sclerosis. Additionally, they provide high-level administrative cores for building research opportunities and conducting complex clinical and economic analyses of healthcare variation. The organization maintains strong partnerships with the Department of Defense and the Department of Health and Human Services. For the Department of Defense, their work focuses on health services research, disaster medicine, military emergency medicine, and comparative effectiveness studies, including qualitative assessments of surgical interventions like hand transplantation. Their work with the Department of Health and Human Services is primarily centered on cutting-edge biomedical research, cellular therapy development, and the application of learning health systems to improve patient outcomes. The contractor's business profile is characterized by its role as a research-intensive medical institution. While they do not hold specific government certifications, they operate as a sophisticated entity capable of managing complex subcontracts and prime awards across multiple federal health and defense portfolios.